Gross profit was down 1.8% to $47.6 million (a GP margin of 43.0%).
After-tax profit rose 40% to $13.2 million, reflecting significantly lower interest expense and $1.9 million one-off insurance proceeds.
There was no goodwill impairment for the year and profit before tax of $18,910 was described as ‘not meaningful’ as was profit after tax of $13,211.
Bank debt was reduced from $47.5 million to $38.5 million during the year, leaving net debt of $27.0 million as at 30 June.
A fully-franked final dividend of 1.25c per ordinary share was recommended by directors. The shares have been trading at about 71.5c.
Plenty of interest in RxSight’s Light Adjustable Lens at AUSCRS
RxSight believes Australian cataract surgeons are ready to embrace a technology that has already transformed refractive cataract surgery overseas, using...
